ISSN 2234-5531
 
 
A submitted manuscript must not be associated with any type of research misconduct, including fabrication, falsification, and plagiarism with intent to deceive by the authors. The cover letter to the Editor-in-Chief must declare that a submitted manuscript has not been published nor is under simultaneous consideration for publication elsewhere in whole or in part in any language except in the form of an abstract. The cover letter must also state if the manuscript contains any portion that may be regarded as redundant or duplicate information, defined as a paper, data, tables, or figures that overlap substantially with already published information. Research involving human subjects must comply with the principles of the Declaration of Helsinki (1964). Articles describing research involving animals must state in the Methods section that the work was approved by the applicable institutional ethics committee or review board. The manuscript must also state that informed consent was obtained from the subjects, when appropriate. The Editor-in-Chief has the right to reject a manuscript if research misconduct is suspected.

Copyrightⓒ Korean Epilepsy Scoiety. All right reserved.
KCC Parktown 101-308, Mallijae-ro 185, Jung-Gu, Seoul, Korea
Tel : +82-70-7591-3489 Fax : +82-2-6969-9608 E-mail : epilepsy@kes.or.kr